A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT02899988. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo- Controlled Study of LY3074828 in Subjects With Moderate-to- Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaluate the efficacy of the study drug mirikizumab in participants with moderate to severe plaque psoriasis.
Study identification
- NCT ID
- NCT02899988
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 205 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2016 (Actual)
- Primary completion
- Jun 19, 2017 (Actual)
- Completion
- May 8, 2019 (Actual)
- Last update posted
- Jun 18, 2020
2016 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Forward Clinical Trials, Inc | Tampa | Florida | 33624 | — |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| The South Bend Clinic | South Bend | Indiana | 46617 | — |
| DS Research | Louisville | Kentucky | 40241 | — |
| Dr. Shondra Smith MD | Lake Charles | Louisiana | 70605 | — |
| Central Dermatology PC | St Louis | Missouri | 63117 | — |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Clinical Partners LLC | Johnston | Rhode Island | 02919 | — |
| Menter Dermatology Research Institute | Dallas | Texas | 75246 | — |
| Dermatology Associates | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02899988, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2020 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02899988 live on ClinicalTrials.gov.